| Notice of AGM & availability of Annual Report | 04-Jun-2026 | 07:00 | RNS |
| Block Listing Six Monthly Return | 01-Jun-2026 | 15:30 | RNS |
| Holding(s) in Company | 22-May-2026 | 12:06 | RNS |
| Unaudited Results for the Year Ended 31 Dec 2025 | 29-Apr-2026 | 07:00 | RNS |
| Notice of Results & Investor Presentation | 20-Apr-2026 | 07:00 | RNS |
| Positive Eroxon® & Eroxon® “Inte... | 23-Mar-2026 | 07:00 | RNS |
| Formal Grant of US Patent | 18-Mar-2026 | 07:00 | RNS |
| Holding(s) in Company | 17-Mar-2026 | 11:37 | RNS |
| Holding(s) in Company | 20-Feb-2026 | 16:06 | RNS |
| Patent notice of allowance granted for the US | 05-Feb-2026 | 07:00 | RNS |
| Trading Update | 04-Feb-2026 | 07:00 | RNS |
| Holding(s) in Company | 13-Jan-2026 | 12:53 | RNS |
| Holding(s) in Company | 13-Jan-2026 | 12:51 | RNS |
| Results of WSD4000 Early Feasibility Study | 12-Jan-2026 | 07:00 | RNS |
| Notification of major holdings | 07-Jan-2026 | 16:34 | RNS |
| Currency | UK Pounds |
| Share Price | 0.58p |
| Change Today | 0.034p |
| % Change | 6.23 % |
| 52 Week High | 13.43 |
| 52 Week Low | 0.55 |
| Volume | 8,950,692 |
| Shares Issued | 581.33m |
| Market Cap | £3.37m |
| Beta | 0.00 |
| RiskGrade | 479 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 2,762 @ 0.58p |
| 16:35 | 2,058 @ 0.58p |
| 16:35 | 333 @ 0.58p |
| 16:35 | 80 @ 0.58p |
| 16:35 | 291 @ 0.58p |
| Finance Director | Angela Hildreth |
| CEO | Alex Duggan |
You are here: research